Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database.

HOME
>
論文・技術情報
>
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database.

Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance database.

アブストラクト	On October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID-19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV) toxicities associated with remdesivir remain unknown. We aimed to characterize the CV adverse drug reactions (ADRs) associated with remdesivir using VigiBase, an individual case safety report database of the World Health Organization (WHO). Disproportionality analyses of CV-ADRs associated with remdesivir were performed using reported odds ratios and information components. We conducted in vitro experiments using cardiomyocytes derived from human pluripotent stem cell cardiomyocytes (hPSC-CMs) to confirm cardiotoxicity of remdesivir. To distinguish drug-induced CV-ADRs from COVID-19 effects, we restricted analyses to patients with COVID-19 and found that, after adjusting for multiple confounders, cardiac arrest (adjusted odds ratio [aOR]: 1.88, 95% confidence interval [CI]: 1.08-3.29), bradycardia (aOR: 2.09, 95% CI: 1.24-3.53), and hypotension (aOR: 1.67, 95% CI: 1.03-2.73) were associated with remdesivir. In vitro data demonstrated that remdesivir reduced the cell viability of hPSC-CMs in time- and dose-dependent manners. Physicians should be aware of potential CV consequences following remdesivir use and implement adequate CV monitoring to maintain a tolerable safety margin.
ジャーナル名	Clinical and translational science
Pubmed追加日	2021/11/1
投稿者	Jung, Se Yong; Kim, Min Seo; Li, Han; Lee, Keum Hwa; Koyanagi, Ai; Solmi, Marco; Kronbichler, Andreas; Dragioti, Elena; Tizaoui, Kalthoum; Cargnin, Sarah; Terrazzino, Salvatore; Hong, Sung Hwi; Abou Ghayda, Ramy; Kim, Nam Kyun; Chung, Seo Kyoung; Jacob, Louis; Salem, Joe-Elie; Yon, Dong Keon; Lee, Seung Won; Kostev, Karel; Kim, Ah Young; Jung, Jo Won; Choi, Jae Young; Shin, Jin Soo; Park, Soon-Jung; Choi, Seong Woo; Ban, Kiwon; Moon, Sung-Hwan; Go, Yun Young; Shin, Jae Il; Smith, Lee
組織名	Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University;College of Medicine, Seoul, Korea.;College of Medicine, Korea University, Seoul, Korea.;Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Samsung;Medical Center, Sungkyunkwan University, Seoul, Korea.;University of Florida College of Medicine, Gainesville, Florida, USA.;Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea.;Research and Development Unit, Parc Sanitari Sant Joan de Deu, Universitat de;Barcelona, Fundacio Sant Joan de Deu, CIBERSAM, Barcelona, Spain.;ICREA, Barcelona, Spain.;Instituto de Salud Carlos III, Centro de Investigacion Biomedica en Red de Salud;Mental, CIBERSAM, Madrid, Spain.;Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.;Department of Mental Health, The Ottawa Hospital, Ottawa, Ontario, Canada.;Ottawa Hospital Research Institute (OHRI) Clinical Epidemiology Program,;University of Ottawa, Ottawa, Ontario, Canada.;Department of Internal Medicine IV, Medical University Innsbruck, Innsbruck,;Austria.;Department of Health, Medicine and Caring Sciences, Pain and Rehabilitation;Centre, Linkoping University, Linkoping, Sweden.;Laboratory Microorganismes and Active Biomolecules, Sciences Faculty of Tunis,;Tunis El Manar University, Tunis, Tunisia.;Department of Pharmaceutical Sciences, Interdepartmental Research Center of;Pharmacogenetics and Pharmacogenomics (CRIFF), University of Piemonte Orientale,;Novara, Italy.;Yonsei University College of Medicine, Seoul, Korea.;Urology Institute, University Hospitals and Case Western Reserve University,;Cleveland, Ohio, USA.;Department of Pediatrics, Emory University, Atlanta, Georgia, USA.;Division of Cardiovascular Surgery, Department of Thoracic and Cardiovascular;Surgery, Yonsei University College of Medicine, Seoul, Korea.;College of Medicine, Ewha Womans University, Seoul, Korea.;Faculty of Medicine, University of Versailles Saint-Quentin-en-Yvelines,;Montigny-le-Bretonneux, France.;Department of Pharmacology, INSERM, CIC-1901 Paris-Est, CLIP Galilee, UNICO-GRECO;Cardio-oncology Program, Pitie-Salpetriere Hospital, Assistance Publique-Hopitaux;de Paris, Sorbonne Universite, Paris, France.;Department of Pediatrics, Seoul National University Children's Hospital, Seoul;National University College of Medicine, Seoul, Korea.;Department of Data Science, Sejong University College of Software Convergence,;Seoul, Korea.;University Clinic of Marburg, Marburg, Germany.;Infectious Disease Research Center, Korea Research Institute of Chemical;Technology, Daejeon, Korea.;Stem Cell Research Institute, T&R Biofab Co. Ltd, Siheung, Korea.;Department of Physiology, Ischemic/Hypoxic Disease Institute, Seoul National;University College of Medicine, Seoul, Korea.;Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR,;China.;Department of Infectious Diseases and Public Health, City University of Hong;Kong, Hong Kong SAR, China.;The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University,;Cambridge, UK.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/34719115/